CompletedNot Applicable

Endoscopic Grading of Intestinal Metaplasia

South Korea242 participantsStarted 2022-03-01

Plain-language summary

Long-term Helicobacter pylori infection causes premalignant gastric conditions, such as atrophic gastritis and intestinal metaplasia. Image-enhanced endoscopy techniques such as narrow-band imaging (NBI) and magnifying endoscopy improve the diagnosis of gastric intestinal metaplasia (GIM). However, there are no comparative data on the utility of NBI and magnifying endoscopy for diagnosing GIM.

Who can participate

Age range20 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gastroscopy can be performed * Pathological analysis can be performed for analysis of gastric atrophy and intestinal metaplasia Exclusion Criteria: * Age \< 20 or \> 80 years * Anemia (serum hemoglobin level \< 10 g/dL) * Severe systemic disease * Advanced chronic liver disease * Use of certain medications, including proton pump inhibitors, H2-receptor antagonists, or antibiotics * History of H. pylori eradication * History of gastric surgery * Recent history of upper gastrointestinal bleeding

What they're measuring

Gastric intestinal metaplasia

Timeframe: 4 weeks

Trial details

NCT IDNCT05345314

SponsorSoonchunhyang University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-02-28

View on ClinicalTrials.gov More Narrow-band Imaging trials